| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80061 |
Lipid panel |
285,864 |
272,249 |
$3.36M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
38,937 |
36,325 |
$2.46M |
| 83036 |
Hemoglobin; glycosylated (A1C) |
250,720 |
238,780 |
$2.15M |
| 80050 |
General health panel |
60,964 |
59,039 |
$1.97M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
50,759 |
48,173 |
$1.96M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
299,074 |
265,068 |
$1.95M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
49,617 |
47,043 |
$1.88M |
| 80053 |
Comprehensive metabolic panel |
230,785 |
211,784 |
$1.81M |
| 86003 |
|
12,567 |
8,349 |
$1.59M |
| 84443 |
Thyroid stimulating hormone (TSH) |
114,640 |
108,289 |
$1.49M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
60,202 |
56,986 |
$1.43M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
10,926 |
10,460 |
$945K |
| 36415 |
Collection of venous blood by venipuncture |
419,127 |
367,569 |
$809K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
76,751 |
71,408 |
$599K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
22,888 |
21,862 |
$554K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12,051 |
11,435 |
$552K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,972 |
11,774 |
$541K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
15,318 |
14,833 |
$529K |
| 84439 |
|
63,960 |
60,535 |
$522K |
| 88142 |
|
20,976 |
20,481 |
$476K |
| 83970 |
|
16,187 |
14,959 |
$457K |
| 84153 |
|
27,168 |
25,870 |
$436K |
| 84403 |
|
16,496 |
15,586 |
$432K |
| 82570 |
|
97,433 |
92,112 |
$422K |
| 86803 |
|
29,041 |
27,593 |
$418K |
| 82043 |
|
85,546 |
81,521 |
$414K |
| 87186 |
|
46,953 |
38,022 |
$398K |
| 87653 |
|
10,061 |
9,735 |
$392K |
| 82607 |
|
28,494 |
27,056 |
$373K |
| 81001 |
|
127,102 |
119,433 |
$362K |
| 87340 |
|
33,225 |
31,772 |
$354K |
| 87536 |
|
4,248 |
3,997 |
$339K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
54,466 |
48,738 |
$336K |
| 82728 |
|
30,038 |
28,202 |
$324K |
| 87070 |
|
34,264 |
31,659 |
$315K |
| 87517 |
|
6,809 |
6,514 |
$294K |
| 86762 |
|
16,981 |
16,311 |
$269K |
| 84402 |
|
9,814 |
9,308 |
$261K |
| 82746 |
|
20,444 |
19,374 |
$256K |
| 87088 |
|
34,445 |
29,722 |
$246K |
| 83550 |
|
30,560 |
28,653 |
$235K |
| 86850 |
|
15,655 |
15,031 |
$228K |
| 82670 |
|
7,408 |
7,047 |
$227K |
| 87480 |
|
10,183 |
9,729 |
$218K |
| 87510 |
|
10,159 |
9,698 |
$213K |
| 86702 |
|
14,306 |
13,911 |
$212K |
| 86706 |
|
18,339 |
17,495 |
$208K |
| 83880 |
|
8,367 |
7,570 |
$207K |
| 82105 |
|
12,947 |
12,276 |
$206K |
| 84550 |
|
60,113 |
56,713 |
$205K |
| 87077 |
|
21,141 |
15,546 |
$204K |
| 87660 |
|
10,063 |
9,652 |
$202K |
| 86592 |
|
41,541 |
39,761 |
$195K |
| 85027 |
|
33,927 |
32,213 |
$194K |
| 83540 |
|
33,329 |
31,275 |
$191K |
| 86704 |
|
15,153 |
14,428 |
$188K |
| 83655 |
|
12,284 |
11,993 |
$185K |
| 83013 |
|
2,649 |
2,572 |
$184K |
| 87390 |
|
9,875 |
9,577 |
$184K |
| 86038 |
|
15,125 |
14,452 |
$177K |
| 87522 |
Neg quan hep c or qual rna |
4,144 |
3,880 |
$173K |
| 82274 |
|
12,587 |
12,132 |
$173K |
| 86359 |
|
4,882 |
4,618 |
$172K |
| 84702 |
|
10,034 |
8,094 |
$161K |
| 86360 |
|
3,638 |
3,435 |
$161K |
| 86008 |
|
2,207 |
1,743 |
$148K |
| 84146 |
|
6,950 |
6,596 |
$148K |
| 84480 |
|
10,532 |
10,119 |
$142K |
| 86701 |
|
14,323 |
13,923 |
$139K |
| 82785 |
|
7,762 |
7,325 |
$138K |
| 83001 |
|
6,814 |
6,551 |
$138K |
| 86480 |
|
2,905 |
2,769 |
$135K |
| 88143 |
|
6,284 |
6,142 |
$135K |
| 83735 |
|
23,396 |
19,960 |
$134K |
| 86235 |
|
2,395 |
2,151 |
$132K |
| 85610 |
|
35,965 |
29,011 |
$129K |
| 86787 |
|
8,945 |
8,461 |
$127K |
| 80074 |
|
2,592 |
2,471 |
$118K |
| 84481 |
|
7,341 |
7,033 |
$117K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,652 |
5,281 |
$111K |
| 86160 |
|
9,273 |
4,840 |
$101K |
| 86140 |
|
20,131 |
17,511 |
$99K |
| 86708 |
|
7,696 |
7,270 |
$99K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,608 |
2,527 |
$99K |
| 86901 |
|
16,398 |
15,739 |
$90K |
| 82378 |
|
5,833 |
4,888 |
$88K |
| 83002 |
|
4,301 |
4,117 |
$84K |
| 86696 |
|
3,546 |
2,825 |
$75K |
| 82533 |
|
4,616 |
4,252 |
$72K |
| 82652 |
|
1,976 |
1,856 |
$71K |
| 84144 |
|
3,287 |
3,058 |
$71K |
| 87902 |
|
308 |
288 |
$69K |
| 82677 |
|
2,338 |
2,268 |
$65K |
| 80069 |
|
11,859 |
10,530 |
$65K |
| 87205 |
|
15,209 |
13,470 |
$64K |
| 86695 |
|
4,386 |
3,452 |
$62K |
| 85730 |
|
11,173 |
10,440 |
$61K |
| 80076 |
|
8,766 |
8,046 |
$58K |
| 84460 |
|
20,117 |
19,229 |
$56K |
| 86431 |
|
10,118 |
9,683 |
$56K |
| 82950 |
|
10,361 |
10,161 |
$55K |
| 87040 |
|
5,088 |
3,243 |
$53K |
| 86900 |
|
16,418 |
15,748 |
$52K |
| 85652 |
|
21,302 |
18,918 |
$52K |
| 83690 |
|
7,620 |
7,234 |
$52K |
| 82627 |
|
2,494 |
2,373 |
$51K |
| 82672 |
|
2,123 |
2,047 |
$51K |
| 86735 |
|
3,197 |
2,973 |
$49K |
| 86225 |
|
3,592 |
3,384 |
$47K |
| 86765 |
|
3,118 |
2,933 |
$47K |
| 84165 |
|
6,402 |
4,769 |
$45K |
| 83525 |
|
4,108 |
3,919 |
$45K |
| 87634 |
|
612 |
602 |
$44K |
| 86800 |
|
2,879 |
2,748 |
$44K |
| 82550 |
|
10,600 |
9,355 |
$44K |
| 82951 |
|
3,110 |
3,025 |
$43K |
| 84450 |
|
14,360 |
13,729 |
$42K |
| 86376 |
|
2,787 |
2,680 |
$41K |
| 82248 |
|
22,970 |
20,922 |
$40K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
4,060 |
3,709 |
$40K |
| 82977 |
|
7,822 |
7,286 |
$40K |
| 82784 |
|
5,376 |
3,260 |
$39K |
| 83520 |
|
2,637 |
2,372 |
$38K |
| 87209 |
|
2,271 |
1,809 |
$38K |
| 87529 |
|
974 |
597 |
$37K |
| 84681 |
|
1,767 |
1,695 |
$37K |
| 84100 |
|
13,536 |
12,102 |
$36K |
| 84156 |
|
14,037 |
12,941 |
$36K |
| 83090 |
|
2,779 |
2,605 |
$35K |
| 83615 |
|
7,412 |
6,301 |
$35K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,084 |
877 |
$34K |
| 80159 |
|
3,271 |
2,423 |
$33K |
| 82150 |
|
4,943 |
4,663 |
$32K |
| 85018 |
|
13,192 |
12,356 |
$32K |
| 84703 |
|
3,603 |
3,499 |
$31K |
| 84425 |
|
1,677 |
1,578 |
$30K |
| 86317 |
|
936 |
894 |
$30K |
| 85014 |
|
12,525 |
11,697 |
$29K |
| 86336 |
|
1,814 |
1,759 |
$29K |
| 80164 |
|
2,721 |
2,458 |
$29K |
| 86677 |
|
1,873 |
1,471 |
$29K |
| 87046 |
|
3,223 |
1,548 |
$29K |
| 83516 |
|
2,047 |
1,545 |
$28K |
| 80197 |
|
3,481 |
2,440 |
$28K |
| 84432 |
|
1,894 |
1,798 |
$28K |
| 87177 |
|
2,988 |
2,418 |
$27K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
71 |
69 |
$27K |
| 86304 |
|
1,351 |
1,197 |
$26K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
680 |
646 |
$25K |
| 82024 |
|
721 |
665 |
$25K |
| 84154 |
|
1,702 |
1,608 |
$24K |
| 81025 |
|
3,043 |
2,935 |
$24K |
| 84166 |
|
1,740 |
1,302 |
$23K |
| 82565 |
|
7,581 |
6,589 |
$23K |
| 82947 |
|
6,931 |
6,617 |
$23K |
| 86300 |
|
1,054 |
917 |
$22K |
| 87045 |
|
2,261 |
2,104 |
$22K |
| 86200 |
|
1,850 |
1,787 |
$22K |
| 83014 |
|
2,614 |
2,536 |
$22K |
| 84484 |
|
2,194 |
1,977 |
$21K |
| 84445 |
|
666 |
655 |
$21K |
| 83721 |
|
2,465 |
2,347 |
$20K |
| 86021 |
|
1,399 |
1,296 |
$18K |
| 83521 |
|
1,390 |
1,233 |
$18K |
| 87899 |
|
1,356 |
1,064 |
$18K |
| 36416 |
|
7,338 |
7,080 |
$18K |
| 85379 |
|
1,887 |
1,785 |
$18K |
| 87081 |
|
2,583 |
2,517 |
$17K |
| 85651 |
|
4,008 |
3,858 |
$16K |
| 84270 |
|
1,331 |
1,274 |
$16K |
| 87338 |
|
1,125 |
1,078 |
$16K |
| 86709 |
|
1,378 |
1,300 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
449 |
376 |
$16K |
| 83921 |
|
1,206 |
1,152 |
$16K |
| 82465 |
|
4,155 |
3,942 |
$16K |
| 86665 |
|
400 |
387 |
$16K |
| 87350 |
|
1,171 |
1,131 |
$15K |
| 87799 |
|
879 |
595 |
$15K |
| 87427 |
|
1,382 |
1,124 |
$15K |
| 86334 |
|
1,053 |
805 |
$14K |
| 84134 |
|
1,351 |
1,209 |
$14K |
| 83718 |
|
1,567 |
1,488 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
801 |
794 |
$13K |
| 83605 |
|
1,231 |
1,136 |
$13K |
| 85045 |
|
3,883 |
3,609 |
$13K |
| 84482 |
|
836 |
800 |
$12K |
| 82952 |
|
2,591 |
2,511 |
$11K |
| 86707 |
|
859 |
833 |
$11K |
| 86147 |
|
213 |
184 |
$10K |
| 86361 |
|
552 |
533 |
$10K |
| 87341 |
|
902 |
863 |
$10K |
| 86036 |
|
1,008 |
934 |
$10K |
| 83021 |
|
616 |
565 |
$10K |
| 82103 |
|
771 |
714 |
$10K |
| 83010 |
|
980 |
913 |
$10K |
| 86381 |
|
470 |
436 |
$10K |
| 82310 |
|
2,703 |
2,543 |
$9K |
| 83883 |
|
589 |
544 |
$9K |
| 87116 |
|
1,361 |
812 |
$9K |
| 84520 |
|
3,775 |
3,628 |
$9K |
| 82140 |
|
799 |
687 |
$9K |
| 80178 |
|
1,463 |
1,284 |
$9K |
| 86301 |
|
620 |
522 |
$9K |
| 86141 |
|
2,271 |
2,048 |
$9K |
| 84155 |
|
3,784 |
3,517 |
$8K |
| 82390 |
|
790 |
727 |
$8K |
| 86364 |
|
717 |
687 |
$8K |
| 87807 |
|
586 |
576 |
$7K |
| 86593 |
|
1,499 |
1,434 |
$7K |
| 82610 |
|
662 |
629 |
$7K |
| 86705 |
|
525 |
504 |
$7K |
| 87015 |
|
1,476 |
902 |
$7K |
| 86255 |
|
436 |
392 |
$7K |
| 87324 |
|
569 |
515 |
$6K |
| 87075 |
|
694 |
626 |
$6K |
| 87449 |
|
559 |
507 |
$6K |
| 87206 |
|
1,559 |
974 |
$6K |
| 82232 |
|
673 |
585 |
$6K |
| 82040 |
|
1,591 |
1,518 |
$5K |
| 84478 |
|
1,163 |
1,066 |
$5K |
| 84132 |
|
1,821 |
1,621 |
$5K |
| 86015 |
|
519 |
484 |
$5K |
| 82247 |
|
1,292 |
1,114 |
$5K |
| 80305 |
|
988 |
893 |
$5K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
39 |
39 |
$5K |
| 81015 |
|
1,502 |
1,397 |
$4K |
| 87497 |
|
131 |
118 |
$4K |
| 85049 |
|
851 |
814 |
$4K |
| 84207 |
|
200 |
193 |
$4K |
| 83825 |
|
227 |
217 |
$4K |
| 83020 |
|
379 |
338 |
$4K |
| 84145 |
|
173 |
166 |
$4K |
| 86769 |
|
497 |
444 |
$3K |
| 84075 |
|
902 |
852 |
$3K |
| 81003 |
|
1,246 |
1,158 |
$3K |
| 82175 |
|
140 |
134 |
$3K |
| 86341 |
|
115 |
102 |
$3K |
| 84300 |
|
655 |
609 |
$2K |
| 83993 |
|
123 |
120 |
$2K |
| 84466 |
|
240 |
228 |
$2K |
| 86663 |
|
157 |
153 |
$2K |
| 86664 |
|
131 |
128 |
$2K |
| 84305 |
|
93 |
87 |
$2K |
| 84436 |
|
288 |
277 |
$2K |
| 80162 |
|
202 |
184 |
$2K |
| 84244 |
|
85 |
83 |
$2K |
| 82088 |
|
42 |
38 |
$2K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
74 |
72 |
$2K |
| 86835 |
|
18 |
12 |
$2K |
| 83930 |
|
337 |
310 |
$2K |
| 80051 |
|
391 |
355 |
$2K |
| 87184 |
|
271 |
231 |
$2K |
| 87269 |
|
126 |
118 |
$2K |
| 85613 |
|
152 |
142 |
$2K |
| 86308 |
|
198 |
192 |
$1K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
1,921 |
1,823 |
$1K |
| 84630 |
|
123 |
117 |
$1K |
| 85048 |
|
599 |
549 |
$1K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
554 |
508 |
$1K |
| 82542 |
|
60 |
53 |
$1K |
| 87481 |
|
21 |
13 |
$960.90 |
| 81050 |
|
372 |
352 |
$919.47 |
| 82668 |
|
89 |
81 |
$873.14 |
| 86692 |
|
45 |
44 |
$872.07 |
| 83498 |
|
29 |
28 |
$789.01 |
| 86060 |
|
101 |
97 |
$773.13 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
21 |
13 |
$737.49 |
| 84295 |
|
409 |
338 |
$728.41 |
| 83935 |
|
146 |
135 |
$705.56 |
| 80177 |
|
73 |
68 |
$631.84 |
| 87102 |
|
68 |
64 |
$609.73 |
| 82985 |
|
56 |
53 |
$582.66 |
| 86337 |
|
24 |
24 |
$515.08 |
| 82525 |
|
51 |
45 |
$503.26 |
| 82340 |
|
84 |
81 |
$487.47 |
| 80202 |
|
41 |
24 |
$460.22 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
28 |
26 |
$385.95 |
| 86880 |
|
54 |
54 |
$366.00 |
| 82507 |
|
15 |
15 |
$363.77 |
| 80143 |
|
27 |
24 |
$300.62 |
| 82166 |
|
15 |
14 |
$293.52 |
| 82803 |
|
16 |
12 |
$289.54 |
| 84133 |
|
81 |
74 |
$259.86 |
| 82530 |
|
16 |
13 |
$251.03 |
| 86780 |
|
16 |
16 |
$247.15 |
| 80156 |
|
19 |
17 |
$236.52 |
| 83945 |
|
17 |
17 |
$191.91 |
| 84590 |
|
16 |
15 |
$177.24 |
| 82435 |
|
80 |
76 |
$163.83 |
| 83519 |
|
12 |
12 |
$155.31 |
| 82397 |
|
14 |
13 |
$136.37 |
| 84560 |
|
29 |
28 |
$126.79 |
| 82374 |
|
38 |
37 |
$117.08 |
| 82575 |
|
12 |
12 |
$109.89 |
| S9999 |
Sales tax |
52,329 |
26,795 |
$94.25 |
| 84105 |
|
14 |
14 |
$68.65 |
| 85004 |
|
15 |
12 |
$61.14 |
| 84392 |
|
14 |
14 |
$49.58 |
| 83986 |
|
13 |
13 |
$43.28 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
14 |
$28.72 |